TY - JOUR
T1 - A newfangled collagenase inhibitor topical formulation based on ethosomes with sambucus nigra l. Extract
AU - Mota, Ana Henriques
AU - Prazeres, Inês
AU - Mestre, Henrique
AU - Bento-Silva, Andreia
AU - Rodrigues, Maria João
AU - Duarte, Noélia
AU - Serra, Ana Teresa
AU - Bronze, Maria Rosário
AU - Rijo, Patrícia
AU - Gaspar, Maria Manuela
AU - Viana, Ana Silveira
AU - Ascensão, Lia
AU - Pinto, Pedro
AU - Kumar, Pradeep
AU - Almeida, António José
AU - Reis, Catarina Pinto
N1 - Funding Information:
Authors also gratefully acknowledge the R?giefrutas, iMed and Funda??o para a Ci?ncia e a Tecnologia (FCT) (UIDB/04138/2020, UIDB/00100/2020, UIDP/50017/2020+UIDB/50017/2020, COFAC/ILIND/CBIOS/1/2020 and CCMAR/Multi/04326/2019 project), Portugal 2020, Portuguese Mass Spectrometry Network (LISBOA-01-0145-FEDER-402-022125), FCT/MCTES for the financial support to CESAM (UIDP/50017/2020, UIDB/50017/2020), INTERFACE Programme (Innovation, Technology and Circular Economy Fund (FITEC) and iNOVA4Health?UIDB/04462/2020, a program financially also supported by FCT. A.T.S. also acknowledge FCT/Minist?rio da Educa??o e Ci?ncia for the Individual Grant CEECIND/04801/2017. The authors are also grateful to Jacinta Pinho from iMED.Ulisboa, Faculty of Pharmacy, University of Lisboa (Lisbon, Portugal) and Jo?o Mota from Faculty of Pharmacy, University of Lisboa (Lisbon, Portugal), as well as Sheila Alves from Instituto de Biologia Experimental e Tecnol?gica (Oeiras, Portugal) in conducting some experiments.
Funding Information:
Funding: Authors also gratefully acknowledge the Régiefrutas, iMed and Fundação para a Ciência e a Tecnologia (FCT) (UIDB/04138/2020, UIDB/00100/2020, UIDP/50017/2020+UIDB/50017/2020, COFAC/ILIND/CBIOS/1/2020 and CCMAR/Multi/04326/2019 project), Portugal 2020, Portuguese Mass Spectrometry Network (LISBOA-01-0145-FEDER-402-022125), FCT/MCTES for the financial support to CESAM (UIDP/50017/2020, UIDB/50017/2020), INTERFACE Programme (Innovation, Technology and Circular Economy Fund (FITEC) and iNOVA4Health—UIDB/04462/2020, a program financially also supported by FCT. A.T.S. also acknowledge FCT/Ministério da Educação e Ciência for the Individual Grant CEECIND/04801/2017.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/5
Y1 - 2021/5
N2 - Sambucus nigra L. (S. nigra) is a shrub widespread in Europe and western Asia, traditionally used in medicine, that has become popular in recent years as a potential source of a wide range of interesting bioactive compounds. The aim of the present work was to develop a topical S. nigra extract formulation based on ethosomes and thus to support its health claims with scientific evidence. S. nigra extract was prepared by an ultrasound-assisted method and then included in ethosomes. The ethosomes were analyzed in terms of their size, stability over time, morphology, entrapment capacity (EC), extract release profile, stability over time and several biological activities. The prepared ethosomes were indicated to be well defined, presenting sizes around 600 nm. The extract entrapment capacity in ethosomes was 73.9 ± 24.8%, with an interesting slow extract release profile over 24 h. The extract-loaded ethosomes presented collagenase inhibition activity and a very good skin compatibility after human application. This study demonstrates the potential use of S. nigra extract incorporated in ethosomes as a potential cosmeceutical ingredient and on further studies should be performed to better understand the impact of S. nigra compounds on skin care over the time.
AB - Sambucus nigra L. (S. nigra) is a shrub widespread in Europe and western Asia, traditionally used in medicine, that has become popular in recent years as a potential source of a wide range of interesting bioactive compounds. The aim of the present work was to develop a topical S. nigra extract formulation based on ethosomes and thus to support its health claims with scientific evidence. S. nigra extract was prepared by an ultrasound-assisted method and then included in ethosomes. The ethosomes were analyzed in terms of their size, stability over time, morphology, entrapment capacity (EC), extract release profile, stability over time and several biological activities. The prepared ethosomes were indicated to be well defined, presenting sizes around 600 nm. The extract entrapment capacity in ethosomes was 73.9 ± 24.8%, with an interesting slow extract release profile over 24 h. The extract-loaded ethosomes presented collagenase inhibition activity and a very good skin compatibility after human application. This study demonstrates the potential use of S. nigra extract incorporated in ethosomes as a potential cosmeceutical ingredient and on further studies should be performed to better understand the impact of S. nigra compounds on skin care over the time.
KW - Collagenase inhibition
KW - Ethosomes
KW - Sambucus nigra L
KW - Skin compatibility
UR - http://www.scopus.com/inward/record.url?scp=85106968696&partnerID=8YFLogxK
U2 - 10.3390/ph14050467
DO - 10.3390/ph14050467
M3 - Article
AN - SCOPUS:85106968696
VL - 14
JO - Pharmaceuticals
JF - Pharmaceuticals
SN - 1424-8247
IS - 5
M1 - 467
ER -